Quantum BioPharma is trading 5.23% down at $3.28 as broader risk-off sentiment pressures U.S. equities.
- Elevated Treasury yields, energy costs, and expectations for a Federal Reserve rate hike are weighing on markets.
- The company announced a September 16, 2026 presentation at the ArcStone-Kingswood Growth Summit; no negative company-specific catalyst was identified.
- The regular session closed unchanged at $3.46, while the NASDAQ Composite declined 0.76%.